The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trial
Open accessAbstract
We conducted a prospective, randomized single-blind trial of propranolol for the prevention of recurrent variceal bleeding. Seventy-nine patients shown to have variceal hemorrhage at endoscopy were included in the study within 72 hr following diagnosis. Fifty-seven patients had alcoholic cirrhosis, 10 cryptogenic cirrhosis, 6 posthepatitic cirrhosis, 4 biliary cirrhosis, 1 portal vein thrombosis without cirrhosis and 1 idiopathic portal hypertension. The severity of liver disease at inclusion was assessed according to the Pugh modification of the Child-Turcotte classification: 9 (11%) had Class A; 41 (52%) Class B and 29 (37%) Class C disease. Patients were randomly assigned by sealed envelope to the propranolol group (42 patients) or the placebo group (37 patients). Propranolol dosage was titrated in order to produce plasma concentrations of propranolol of 50 to 150 ng per ml. β-blockade was also confirmed by isoproterenol testing. The cumulative percentages of patients free of rebleeding 1 and 2 years after inclusion were 31 and 21% in the propranolol group, and 25 and 17% in the placebo group; both differences were not significant. Cumulative 1 and 2 years survival were also comparable: 64 and 54% in the propranolol group vs. 70 and 63% in the placebo group. There was no evidence for a therapeutic effect of propranolol after adjusting for potential confounding variables by multiple logistic regression. We conclude that propranolol is not effective for the prevention of variceal rebleeding, when administered early following the initial bleed, in cirrhotics unselected with respect to the severity of the liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941 · cited 1×
“The two groups did not differ markedly in age, sex, etiology of liver disease, previous episodes of gastrointestinal bleeding or alcohol consumption at the time of inclusion, but more patients in the propranolol group had severe (Class C) liver disease, graded on admission by the Pugh modification of the Child-Turcott…”
MethodIntroduction to sample size determination and power analysis for clinical trials
Lachin, J. M. (1981) · Controlled Clinical Trials · doi:10.1016/0197-2456(81)90001-5 · Cited by 1,012
Cited by
The treatment of portal hypertension: A meta-analytic review
D'amico, G., Pagliaro, L., & Bosch, J. (1995) · Hepatology · doi:10.1002/hep.1840220145 · Cited by 1,015
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
Tripathi, D., Stanley, A. J., Hayes, P. C., Patch, D., Millson, C., Mehrzad, H., Austin, A., Ferguson, J. W., Olliff, S. P., Hudson, M., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309262 · Cited by 795
Gastroesophageal Variceal Hemorrhage
Sharara, A. I., & Rockey, D. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003007 · Cited by 425
Infante-Rivard, C., Esnaola, S., & Villeneuve, J.-P. (1987) · Hepatology · doi:10.1002/hep.1840070408 · Cited by 320
Self-citationPascal, J.-P., Cales, P., & A Multicenter Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198710013171403 · Cited by 297
Metadata
- Authors
- Villeneuve, J.-P., Pomier-Layrargues, G., Infante-Rivard, C., Willems, B., Huet, M. P., Marleau, D., & Viallet, A.
- Venue
- Hepatology
- Published
- 1986-11
- Volume
- 6
- Issue
- 6
- Pages
- 1239-1243
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2022990509
- Cited by
- 158
- References
- 2
- FWCI
- 18.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.